Eva Arranz

Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes.

Françesc Solé, Elisa Luño, Carmen Sanzo et al. · PubMed · 2005 · 217 citations

Life Sciences, Genetics, Hematology +17

Hypermethylation of a 5′ CpG island of p16 is a frequent event in non-Hodgkin’s lymphoma

Beatriz Martínez–Delgado, José Fernández‐Piqueras, Eva Arranz et al. · Leukemia · 1997 · 83 citations

Veterinary Medicine, Molecular Biology, Oncology +8

Genetic instability of microsatellites in hematological neoplasms.

Mercedes Robledo, Brendon Martinez, Eva Arranz et al. · PubMed · 1995 · 63 citations

Medicine, Genetics, Hematology +14

Chronic myeloid leukemia patients resistant to or intolerant of interferon alpha and subsequently treated with imatinib show reduced immunoglobulin levels and hypogammaglobulinemia.

Juan Luis Steegmann, Gemma Moreno, Concepción Aláez et al. · PubMed · 2003 · 49 citations

Medicine, Hematology, Immunology +17

Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-

Mar Mallo, Leonor Arenillas, Blanca Espinet et al. · Haematologica · 2008 · 42 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17